Heartflow Inc. announced new analyses from the FISH&CHIPS study, a real-world, multicenter, retrospective study involving over 90,000 patients conducted by the National Health Service in England. The results, which were presented at the European Society of Cardiology's European Association of Cardiovascular Imaging conference in Vienna, indicate that Heartflow FFRCT Analysis derived from coronary computed tomography angiography improves diagnostic decision-making, predicts future cardiovascular events, and delivers system-wide cost savings. Additional findings from a subset of the study were previously presented at the American Heart Association Scientific Sessions 2025, validating Heartflow Plaque Analysis as a predictor of future heart attacks or cardiovascular death.